Monitoring Banned Veterinary Drugs and Mycotoxins

The order establishes government responsibility to issue a strengthened program to address feed and food safety and quality concerns.
It directs strict monitoring and surveillance to protect human life and health.
It focuses on preventing the presence and residue of banned veterinary and beta-agonist drugs in livestock, poultry, aquaculture production, and downstream food products.
It targets prevention and control of mycotoxins entering the food chain through contaminated animal feeds.
It strengthens compliance with the withdrawal period for prescription or ethical veterinary drugs.

The order addresses banned veterinary drugs including Chloramphenicol, Carbadox, Olaquindox, and Nitrofurans.
It addresses beta-agonist drugs including Clenbuterol, Salbutamol, Terbutalin, and Pirbuterol.
It addresses mycotoxins produced by molds or fungi including aflatoxin, ochratoxin, zearalenone, fumonisin, and vomitoxin.
It covers the presence of these prohibited substances in livestock, poultry and aquaculture feeds and their carry-over into animal tissues and food products.
It includes monitoring for prohibited substances whether present through feeds, water, or other means.

The order treats Chloramphenicol as a drug whose use in food animals may cause residue build up leading to aplastis anemia and/or resistance when ingested by humans.
The order treats Carbadox, Olaquindox, and Nitrofurans as possessing genotoxic potential, recognized as mutagenic and carcinogenic.
The order treats beta-agonists including Clenbuterol, Salbutamol, Terbutalin, and Pirbuterol as banned for use in food animals as lean-meat enhancing agents.
The order treats beta-agonists as banned based on the safety profile being not established.
The order identifies mycotoxins as potent liver toxins and active carcinogens that cause liver damage, liver necrosis, and hepatic tumors in animals and may lead to death.

The order requires strict monitoring and surveillance for banned veterinary and beta-agonist drugs in livestock, poultry, and aquaculture feeds.
The order covers the detection of banned drugs in the resulting tissues of livestock, poultry, and aquaculture production.
The order targets residues in meat, fishery products, milk, and eggs.
The order requires attention to the presence of mycotoxins in feeds and the potential carry-over into milk and edible animal tissues.
The order includes surveillance concerns related to banned, misbranded, counterfeit, unregistered, unsafe, unlabelled, tampered, and/or altered veterinary and beta-agonist drugs.

The order governs strict monitoring and surveillance to address banned and unsafe veterinary drug use and distribution practices in livestock, poultry, and aquaculture production.
The order governs strict monitoring and surveillance for the presence of mycotoxins in feeds.
The order requires strict implementation of rational use of prescription or ethical veterinary drugs in livestock, poultry, and aquaculture production.
The order directs strict implementation of the withdrawal period for prescription or ethical veterinary drugs in livestock, poultry, and aquaculture production.
The order emphasizes that Codes of Good Practices, Quality Assurance Programs, Herd Health Surveillance Programs, and education programs are important parts of good husbandry practices.

The order takes immediate effect upon approval.
The order supersedes all other orders inconsistent with BAI Administrative Order No. 13.
The order is adopted under the Department of Agriculture’s authority vested in the issuing Secretary.
The order is recommended for approval by Davin io P. Catbagan, DVM, Officer-in-Charge, Bureau of Animal Industry.